BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 20576822)

  • 1. Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease.
    Kanbay M; Nicoleta M; Selcoki Y; Ikizek M; Aydin M; Eryonucu B; Duranay M; Akcay A; Armutcu F; Covic A
    Clin J Am Soc Nephrol; 2010 Oct; 5(10):1780-6. PubMed ID: 20576822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of serum calcitonin with coronary artery disease in individuals with and without chronic kidney disease.
    Kanbay M; Wolf M; Selcoki Y; Solak Y; Ikizek M; Uysal S; Segall L; Armutcu F; Eryonucu B; Duranay M; Goldsmith D; Covic A
    Int Urol Nephrol; 2012 Aug; 44(4):1169-75. PubMed ID: 22130958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGF23: fashion or physiology?
    Wolf M
    Clin J Am Soc Nephrol; 2010 Oct; 5(10):1727-9. PubMed ID: 20847097
    [No Abstract]   [Full Text] [Related]  

  • 4. Fetuin-A and kidney function in persons with coronary artery disease--data from the Heart and Soul Study.
    Ix JH; Chertow GM; Shlipak MG; Brandenburg VM; Ketteler M; Whooley MA
    Nephrol Dial Transplant; 2006 Aug; 21(8):2144-51. PubMed ID: 16644775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism.
    Evenepoel P; Meijers B; Viaene L; Bammens B; Claes K; Kuypers D; Vanderschueren D; Vanrenterghem Y
    Clin J Am Soc Nephrol; 2010 Jul; 5(7):1268-76. PubMed ID: 20448073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mineral abnormalities and long-term graft function in pediatric renal transplant recipients: a role for FGF-23?
    Wesseling-Perry K; Tsai EW; Ettenger RB; Jüppner H; Salusky IB
    Nephrol Dial Transplant; 2011 Nov; 26(11):3779-84. PubMed ID: 21441401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function.
    Roos M; Lutz J; Salmhofer H; Luppa P; Knauss A; Braun S; Martinof S; Schömig A; Heemann U; Kastrati A; Hausleiter J
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):660-5. PubMed ID: 17970775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of serum intact parathyroid hormone with lower estimated glomerular filtration rate.
    Muntner P; Jones TM; Hyre AD; Melamed ML; Alper A; Raggi P; Leonard MB
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):186-94. PubMed ID: 19019998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disordered FGF23 and mineral metabolism in children with CKD.
    Portale AA; Wolf M; Jüppner H; Messinger S; Kumar J; Wesseling-Perry K; Schwartz GJ; Furth SL; Warady BA; Salusky IB
    Clin J Am Soc Nephrol; 2014 Feb; 9(2):344-53. PubMed ID: 24311704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of fibroblast growth factor 23 and fetuin--A to coronary atherosclerosis.
    Akin F; Celik O; Altun I; Ayca B; Diker VO; Satılmıs S; Sahin C
    J Diabetes Complications; 2015; 29(4):550-5. PubMed ID: 25772252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
    Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N
    Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of serum FGF-23, MGP and fetuin-A on calcium-phosphate metabolism in maintenance hemodialysis patients.
    Xiao DM; Wu Q; Fan WF; Ye XW; Niu JY; Gu Y
    Hemodial Int; 2013 Oct; 17(4):483-92. PubMed ID: 23490272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial differences in markers of mineral metabolism in advanced chronic kidney disease.
    Jovanovich A; Chonchol M; Cheung AK; Kaufman JS; Greene T; Roberts WL; Smits G; Kendrick J;
    Clin J Am Soc Nephrol; 2012 Apr; 7(4):640-7. PubMed ID: 22383748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of serum FGF-23, klotho, fetuin-A, osteopontin, osteoprotegerin and hs-CRP levels with coronary artery disease.
    Göçer K; Aykan AÇ; Kılınç M; Göçer NS
    Scand J Clin Lab Invest; 2020 Jul; 80(4):277-281. PubMed ID: 32077762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Cinacalcet and Vitamin D Analogs on Fibroblast Growth Factor-23 during the Treatment of Secondary Hyperparathyroidism.
    Sprague SM; Wetmore JB; Gurevich K; Da Roza G; Buerkert J; Reiner M; Goodman W; Cooper K
    Clin J Am Soc Nephrol; 2015 Jun; 10(6):1021-30. PubMed ID: 25873267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paricalcitol regulatory effect on inflammatory, fibrotic and anticalcificating parameters in renal patiente. Far beyond mineral bone disease regulation.
    Salanova Villanueva L; Gil Giraldo Y; Santos Sánchez-Rey B; Aguilera Peralta A
    Nefrologia (Engl Ed); 2020; 40(2):171-179. PubMed ID: 31740151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GFR-Specific versus GFR-Agnostic Cutoffs for Parathyroid Hormone and Fibroblast Growth Factor-23 in Advanced Chronic Kidney Disease.
    Canney M; Djurdjev O; Tang M; Zierold C; Blocki F; Wolf M; Levin A
    Am J Nephrol; 2019; 50(2):105-114. PubMed ID: 31238301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor 23 (FGF23) and early chronic kidney disease in the elderly.
    Chudek J; Kocełak P; Owczarek A; Bożentowicz-Wikarek M; Mossakowska M; Olszanecka-Glinianowicz M; Wiecek A
    Nephrol Dial Transplant; 2014 Sep; 29(9):1757-63. PubMed ID: 24729016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uric acid and pentraxin-3 levels are independently associated with coronary artery disease risk in patients with stage 2 and 3 kidney disease.
    Kanbay M; Ikizek M; Solak Y; Selcoki Y; Uysal S; Armutcu F; Eryonucu B; Covic A; Johnson RJ
    Am J Nephrol; 2011; 33(4):325-31. PubMed ID: 21389698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.
    Gutiérrez OM; Januzzi JL; Isakova T; Laliberte K; Smith K; Collerone G; Sarwar A; Hoffmann U; Coglianese E; Christenson R; Wang TJ; deFilippi C; Wolf M
    Circulation; 2009 May; 119(19):2545-52. PubMed ID: 19414634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.